NEW YORK – Teva Pharmaceutical said it will stop selling its migraine patch treatment Zecuity after users reported burns and scars where it was applied, according to CBS News.
The company said anyone who has a patch should not use it.
Zecuity is a disposable battery-powered patch applied to the upper arm or thigh to ease migraine headaches. The patch delivers medicine through the skin.
The U.S. Food and Drug Administration says some users reported severe redness, skin discoloration, cracked skin and pain where the patch was applied.
Teva, based in Israel, said it is recalling Zecuity from pharmacies and is working with the FDA to figure out what is causing the skin reactions.
Our Migraine Patch Lawyers Can Help You
Our dangerous drug attorneys can help if you or someone you care about was harmed by a migraine patch. Lawsuits have been filed against the drug maker by both patients and their families seeking compensation for injuries caused by this dangerous drug. You may be entitled to a settlement. We do not charge any legal fees unless you receive a settlement and we pay all of the case costs. If your claim is not successful for any reason, you do not owe us anything. We put it in all in writing for you. Our migraine patch lawyers will help you file your lawsuit.
Our No Fee Promise on Migraine Patch Cases
You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:
- No money to get started
- We pay all case costs and expenses
- No legal fees whatsoever unless you receive a settlement
- Phone calls are always free.
Start Your Migraine Patch Claim
Our migraine patch lawyers will help you file your lawsuit. To get started, you can:
- Submit the Free Case Review Box on this page, or
- Call (866) 280-3417 any time of day to tell us about your case.
We will listen to your story and answer your questions. If you have claim, we will start immediately.
WARNING: There are strict time deadlines for filing migraine patch lawsuit claims.